Liver carcinoma
Item
diagnosis of hcc with clinically documented cirrhosis and one or more of the following:
boolean
C2239176 (UMLS CUI [1])
liver mass
Item
liver mass (>= 1 cm) with arterial phase contrast enhancement and early washout on subsequent phases by ct; or
boolean
C0240225 (UMLS CUI [1])
alpha-feto protein
Item
suggestive imaging findings plus alpha-feto protein (afp) > 200 mg/dl; or
boolean
C0436162 (UMLS CUI [1])
Neoplasms
Item
tumor confirmed by arteriography
boolean
C0027651 (UMLS CUI [1])
C0003844 (UMLS CUI [2])
Liver carcinoma
Item
patients with a diagnosis or suspicion of hcc who are candidates for resection surgery but do not meet milan criteria for liver transplant
boolean
C2239176 (UMLS CUI [1])
written informed Consent
Item
each patient must provide written informed consent and have completed conventional imaging and staging and ct (multiphase) before initiation of the investigational pet studies
boolean
C0021430 (UMLS CUI [1])
prior malignancy
Item
patients with a known prior malignancy within five years, except basal cell carcinoma of the skin, carcinoma in situ of the cervix, and prior hcc, are excluded
boolean
C0006826 (UMLS CUI [1])
pregnant and breastfeeding
Item
pregnant and breastfeeding patients
boolean
C0549206 (UMLS CUI [1,1])
C0006147 (UMLS CUI [1,2])
diabetes mellitus
Item
patients with poorly controlled diabetes mellitus (fasting blood glucose level > 200 mg/dl)
boolean
C0011849 (UMLS CUI [1])
infiltrative variant of hcc
Item
patients with a known infiltrative variant of hcc
boolean
C1304298 (UMLS CUI [1])
prior treatment within 1 year for hcc
Item
prior treatment within 1 year for hcc
boolean
C1514463 (UMLS CUI [1])